MANAGEMENT OF CHRONIC HEPATITIS C PATIENTS WITH SCHIZOPHRENIA: SHOULD WE TREAT?

被引：0
|
作者：
Barakat, Fatma [1 ]
Barber, Ed [1 ]
Oliver, Deanna L. [1 ]
Petcharaporn, Lita [1 ]
Karlen, Naomi [1 ]
Richards, Lisa M. [1 ]
Alpert, Elliot [1 ]
Perry, William [1 ]
Hassanein, Tarek [1 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1338
引用
收藏
页码：905A / 906A
页数：2
相关论文
共 50 条
  • [31] Interferon-ribavirin-nonresponders in chronic hepatitis C - Should we retreat?
    Wiese, M
    Kullig, U
    Herrmann, A
    Porst, H
    JOURNAL OF HEPATOLOGY, 2003, 38 : 181 - 181
  • [32] Management of patients with chronic hepatitis C infection
    S. K. Herrine
    S. Rossi
    V. J. Navarro
    Clinical and Experimental Medicine, 2006, 6
  • [33] Management of patients with chronic hepatitis C infection
    Herrine, SK
    Rossi, S
    Navarro, VJ
    CLINICAL AND EXPERIMENTAL MEDICINE, 2006, 6 (01) : 20 - 26
  • [34] Should the patients with histologically mild chronic hepatitis C be treated?
    Castéra, L
    Bastie, A
    Roudot-Thoraval, F
    Zafrani, ES
    Pawlotsky, JM
    Dhumeaux, D
    JOURNAL OF HEPATOLOGY, 2000, 32 : 38 - 38
  • [35] Should we be targeting sleep architecture to more effectively treat schizophrenia?
    Luu, Brent
    Rodway, George W.
    Rice, Elizabeth
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (12): : 52 - 54
  • [36] Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions
    Hung, Chia-Chun
    Loh, El-Wui
    Hu, Tsung-Ming
    Chiu, Hsien-Jane
    Hsieh, Hung-Chieh
    Chan, Chin-Hong
    Lan, Tsuo-Hung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2012, 75 (06) : 275 - 280
  • [37] Hepatitis C:: Who should you treat and how?
    Tapias, JMS
    Rodés, J
    BLOOD PURIFICATION, 2002, 20 (01) : 124 - 136
  • [38] Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C
    Ward, RP
    Kugelmas, M
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (04) : 655 - 662
  • [39] SHOULD WE SWITCH TO TENOFOVIR ALAFENAMIDE FOR ALL PATIENTS WITH CHRONIC HEPATITIS B?
    Vishwakarma, Piyush
    V. Kulkarni, Anand
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (03) : 1003 - 1004
  • [40] Hepatitis C: Who should we be treating?
    Kirchner, JT
    AMERICAN FAMILY PHYSICIAN, 1999, 59 (02) : 273 - +
12345